Evidence map›Paper›PMID 31649635›Full record

ArticleFrontiers in microbiology2019

Co-resistance to Amoxicillin and Tetracycline as an Indicator of Multidrug Resistance in

Clémence Bourély, Géraldine Cazeau, Nathalie Jarrige, Eric Jouy, Marisa Haenni, Agnese Lupo, Jean-Yves Madec, Agnès Leblond, Emilie Gay

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Evaluation of qPCR for QuantifyingAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Occurrence of Phenotypic Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Antimicrobial Susceptibility Profiles ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Antimicrobial Susceptibility Profiles ofAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Prevalence and Characterization ofPathogens (Basel, Switzerland) · 2023
    Article
  11. High Occurrence of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Development of multidrug-resistantVeterinary world · 2022
    Article
  14. Article
  15. Evidence of Another Anthropic Impact onAntibiotics (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Multidrug Resistance ofFrontiers in veterinary science · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Clémence BourélyÉcole Nationale des Services Vétérinaires, ENSV, VetAgro Sup, Marcy l'Étoile, France.
Géraldine CazeauANSES, Laboratoire de Lyon, Unité Épidémiologie et Appui à la Surveillance, Université de Lyon, Lyon, France.
Nathalie JarrigeANSES, Laboratoire de Lyon, Unité Épidémiologie et Appui à la Surveillance, Université de Lyon, Lyon, France.
Eric JouyLaboratoire de Ploufragan-Plouzané-Niort, ANSES, Unité Mycoplasmologie Bactériologie Antibiorésistance, Université Bretagne Loire, Technopôle Saint-Brieuc Armor, Ploufragan, France.
Marisa HaenniANSES, Laboratoire de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Université de Lyon, Lyon, France.
Agnese LupoANSES, Laboratoire de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Université de Lyon, Lyon, France.
Jean-Yves MadecANSES, Laboratoire de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Université de Lyon, Lyon, France.
Agnès LeblondEPIA, UMR 0346, Epidémiologie des Maladies Animales et Zoonotiques, INRA, VetAgro Sup, University of Lyon, Marcy l'Étoile, France.
Emilie GayANSES, Laboratoire de Lyon, Unité Épidémiologie et Appui à la Surveillance, Université de Lyon, Lyon, France.
Université Claude Bernard Lyon 1 · FRUniversité Bretagne Loire · FRVetAgro Sup · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine the relevance of co-resistance to amoxicillin and tetracycline as an indicator of multidrug resistance (MDR) in animal health.

methods

resultsIn total, 55,904 isolates were analyzed. MDR proportions were variable among animal species, ranging from 21.9% [20.2; 23.7] in horses to 56.0% [55.4; 56.7] in cattle. A similar situation was observed for proportions of isolates with co-resistance to amoxicillin and tetracycline, with the highest value for cattle 65.0% [64.3; 65.6]. This co-resistance was also most often associated with resistance to other antibiotics, regardless of the animal species considered. Comparative analysis showed substantial agreement between MDR and this co-resistance, with a kappa value of 0.75, all animal species considered.

conclusionGiven the widespread use of penicillins and tetracyclines in animal health, co-resistance to amoxicillin and tetracycline could be an efficient indicator of MDR in

Indexed as

animal healthantimicrobial resistanceE. colimultidrug resistanceRESAPATH

Identifiers

PMID31649635
PMCPMC6794424
OpenAlexW2979812162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.